- No products in the cart.
HCV-IN-31 – CAS 1998705-62-6
€400 – €1500
HCV-IN-31 – CAS 1998705-62-6 is synthesized by Santiago Lab (Prague, Czech Republic).
Purity (LC-MS)
min 95%
Package contents
HCV-IN-31
This compound is for research use only. We do not sell to patients.
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10 mg | In stock |
€400 | |
| 100 mg | In stock |
€1500 |
HCV-IN-31 – CAS 1998705-62-6
Characterisation
CAS: 1998705-62-6
IUPAC Name: (2R,3R,4R,5R)-5-[2-amino-6-(methylamino)purin-9-yl]-4-fluoro-2-(hydroxymethyl)-4-methyloxolan-3-ol
Other names: GLXC-25726, HY-138305
Molecular weight: 312.30 g/mol
Molecular formula: C12H17FN6O3
InChI: InChI=1S/C12H17FN6O3/c1-12(13)7(21)5(3-20)22-10(12)19-4-16-6-8(15-2)17-11(14)18-9(6)19/h4-5,7,10,20-21H,3H2,1-2H3,(H3,14,15,17,18)/t5-,7-,10-,12-/m1/s1
Description
HCV-IN-31 is an HCV inhibitor, with an EC50/EC95 of 15.7 μM for HCV replicon. It is a parent nucleoside of the drug Bemnifosbuvir.
References
- https://doi.org/10.1371/journal.pone.0227104
- WO2019200005 A1 2019-10-17
- WO2018048937 A1 2018-03-15
Chemicals are distributed worldwide
Buy HCV-IN-31 now, and get your order in 48 hours
- Shipping through DHL in 48 hours
- All compounds are safely and rigorously packed
Payment
- We are sending the invoice on the same day as the shipment
- We are able to modify the invoice for the academic institution so that the order can be paid from the grants
